Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti -N -methyl- d -aspartate receptor encephalitis
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 480, 79-83
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673950)
- Guangdong Provincial Science and Technology Plan Projects (2016A020215101, 2017A020215182)
This publication has 19 references indexed in Scilit:
- S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: A postmortem studyJournal of Psychiatric Research, 2013
- Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiologyAutoimmunity Reviews, 2012
- S100B in neuropathologic states: The CRP of the brain?Journal of Neuroscience Research, 2007
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007
- Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery InfarctionArchives of Neurology, 2005
- Spatial and temporal expression of S100B in cells of oligodendrocyte lineageGlia, 2005
- Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing BrainScience, 1999
- Neuron-Specific Enolase as a Marker of in Vitro Neuronal Damage. Part I: Assessment of Neuron-Specific Enolase as a Quantitative and Specific Marker of Neuronal DamageJournal of Neurosurgical Anesthesiology, 1993
- Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarctionEuropean Journal of Clinical Investigation, 1991
- Neuron Specific Enolase, A Clinically Useful Marker for Neurons and Neuroendocrine CellsAnnual Review of Neuroscience, 1987